BIOCRYST PHARM (BO1 BE) stock market data APIs
€7.6427
0(0%)
as of July 2, 2025
Try our APIs with
free plan!
BIOCRYST PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BO1.BE.
Prev. Close
7.6427
Open
7.6427
High
7.6427
Low
7.6427
52 wk Range
5.674-9.896
Market Cap
1 856 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIOCRYST PHARM data using free add-ons & libraries
Get BIOCRYST PHARM Fundamental Data
BIOCRYST PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIOCRYST PHARM News
New
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks were slipping late Friday afternoon, with the NYSE Health Care Index and the Heal PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
BioCryst Pharmaceuticals, Inc. —Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones— —B...
Zacks.com featured highlights ASR, INSW, BCRX, ASC and RRGB
For Immediate Release Chicago, IL – June 26, 2025 – The stocks in this week’s article are Grupo Aeroportuario del Sureste ASR, International Seaways INSW, BioCryst Pharmaceuticals BCRX, Ardmore...
BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock?
BioCryst Pharmaceuticals (BCRX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
